Evidence map›Paper›PMID 40164856›Full record

ArticleTropical animal health and production2025

Factors influencing Akabane virus seroprevalence in sheep and goats in Egypt's Nile Delta.

Abdelfattah Selim, Mohamed Marzok, Hattan S Gattan, Abdelrahman M Hereba

Abstract read
PubMed Publisher
In one paragraph

Article in Tropical animal health and production, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Research progress on the N gene of Akabane virus.Frontiers in veterinary science · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Abdelfattah SelimDepartment of Animal Medicine (Infectious Diseases), Faculty of Veterinary Medicine, Benha University, Toukh, 13736, Egypt. Abdelfattah.selim@fvtm.bu.edu.eg.ORCID http://orcid.org/0000-0002-0211-2853
Mohamed MarzokDepartment of Clinical Sciences, College of Veterinary Medicine, King Faisal University, Al-Ahsa, 31982, Saudi Arabia. mmarzok@kfu.edu.sa.
Hattan S GattanDepartment of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia.
Abdelrahman M HerebaDepartment of Microbiology, College of Veterinary Medicine, King Faisal University, Al-Ahsa, 31982, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to investigate the seroprevalence of Akabane virus (AKAV) in sheep and goats in the Nile Delta of Egypt. A total of 820 samples were collected, consisting of 420 sheep and 400 goats, from four governorates and analyzed using competitive enzyme-linked immunosorbent assay (cELISA). The overall seroprevalence of AKAV was found to be 12.8%, with rates of 11.9% in sheep and 13.8% in goats. Furthermore, the seroprevalence of AKAV infection was significantly associated with various factors, including sex, age, flock size, history of abortion, and the presence of vectors. The odds of AKAV infection were significantly increased twofold in females with a history of abortion, threefold in older animals, and in the presence of vectors. Additionally, the odds were eight times higher in animals raised in flocks of more than twenty. The findings emphasize the need for enhanced surveillance and control measures to mitigate the spread of AKAV, particularly in high-risk populations.

Indexed as

Bunyaviridae InfectionsGoat DiseasesOrthobunyavirusSheep DiseasesAnimalsAntibodies, ViralEgyptEnzyme-Linked Immunosorbent AssayFemaleGoatsMaleRisk FactorsSeroepidemiologic StudiesSheepAntibodies, ViralAkabane diseaseEgyptGoatsSerologySheep

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.